Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
A hemolyzed sample means red blood cells broke open during or after the blood draw, spilling potassium, hemoglobin, and enzymes into the serum and skewing results for tests like potassium, LDH, and bilirubin. Labs flag and reject these specimens because the reported values could look dangerously abnormal when your actual levels are fine, so a redraw protects you from unnecessary treatment or missed findings; several causes and exceptions matter here, and the complete answer below explains which ones apply to you. Common triggers include a needle that is too narrow, prolonged tourniquet time, vigorous tube shaking, difficult veins, or delayed transport, though rarely hemolysis reflects a true condition inside the body such as hemolytic anemia or a transfusion reaction, which is why context and repeat testing matter. If your redraw keeps coming back hemolyzed, or you have fatigue, pale or yellowing skin, dark urine, or shortness of breath, those symptoms deserve a closer look rather than being dismissed as a lab error. Take a free, instant, anonymous symptom check to see which explanations fit your situation and what to ask at your next appointment, since understanding whether this is a simple collection issue or a sign worth investigating helps you move forward with confidence instead of waiting and worrying.
Last reviewed for medical accuracy: 09/29/2026
When your lab report notes a sample as “hemolyzed,” it means red blood cells (RBCs) have broken open, spilling their contents into the serum or plasma. Hemolysis is one of the most common reasons a blood test may be flagged and, in some cases, redrawn. Understanding what hemolysis means and why it matters can help you stay informed and advocate for more accurate results.
• In vitro vs. in vivo
• Lab notation
When red blood cells rupture, they release intracellular components (like potassium, lactate dehydrogenase, hemoglobin) into the liquid part of the sample. This can:
Falsely elevate or lower test values.
• Potassium levels often appear artificially high.
• Enzymes (LDH, AST) can spike, mimicking tissue injury.
• Hemoglobin in the serum interferes with color-based assays.
Trigger misdiagnoses or unnecessary follow-up.
• A lab may report hyperkalemia (high potassium) when you’re actually normal.
• Doctors might order extra tests, imaging, or even treatment based on faulty data.
Collection Technique
Sample Handling
Patient-Related Factors
Labs follow standardized criteria to decide if a hemolyzed sample is usable:
A redraw ensures that your diagnosis and treatment plans are based on trustworthy data.
| Test | Hemolysis Effect |
|---|---|
| Potassium | Falsely high |
| Lactate dehydrogenase (LDH) | Elevated |
| Aspartate transaminase (AST) | Elevated |
| Bilirubin | Can appear low (interference) |
| Hemoglobin | Artificial increase |
Even small degrees of hemolysis can nudge results across decision thresholds. That’s why laboratories and clinicians err on the side of caution.
You have a role in ensuring a smooth, accurate blood draw:
These simple steps can reduce the risk of requiring a repeat draw.
If you’re unsure whether a test result is valid—or if you’re experiencing symptoms—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker, to guide your next steps. Free, online symptom check, using the doctor approved Ubie Symptom Checker
Hemolysis on its own in a lab sample usually isn’t a medical emergency, but if you’re experiencing any of the following, speak to a doctor right away:
Always reach out to a healthcare professional for life-threatening or serious symptoms.
Accurate blood test results are a cornerstone of safe, effective medical care. If you have any concerns—about hemolysis, test findings, or symptoms—speak to your doctor to ensure you’re on the right track.
(References)
* Tamul KR, Schmitz JL, Kane K, Folds JD. Comparison of the effects of Ficoll-Hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic malignancies. Clin Diagn Lab Immunol. 1995 May;2(3):337-42. doi: 10.1128/cdli.2.3.337-342.1995. PMID: 7545079; PMCID: PMC170156.
* LEVINE RA, KLATSKIN G. UNCONJUGATED HYPERBILIRUBINEMIA IN THE ABSENCE OF OVERT HEMOLYSIS. IMPORTANCE OF ACQUIRED DISEASE AS AN ETIOLOGIC FACTOR IN 366 ADOLESCENT AND ADULT SUBJECTS. Am J Med. 1964 Apr;36:541-52. doi: 10.1016/0002-9343(64)90102-0. PMID: 14142407.
* BLACKWELL RQ, HUANG JT. SIMPLIFIED PREPARATION OF BLOOD HEMOLYSATES FOR HEMOGLOBIN ELECTROPHORESIS. Clin Chem. 1965 Jun;11:628-32. PMID: 14300079.
* MICHAUELSSON M, SJOELIN S. HAEMOLYSIS IN BLOOD SAMPLES FROM NEWBORN INFANTS. Acta Paediatr Scand. 1965 Jul;54:325-30. doi: 10.1111/j.1651-2227.1965.tb06379.x. PMID: 14343441.
* Harr KE, Raskin RE, Heard DJ. Temporal effects of 3 commonly used anticoagulants on hematologic and biochemical variables in blood samples from macaws and Burmese pythons. Vet Clin Pathol. 2005 Dec;34(4):383-8. doi: 10.1111/j.1939-165x.2005.tb00065.x. PMID: 16270264.
* Aasland KE, Skjerve E, Smith AJ. Quality of blood samples from the saphenous vein compared with the tail vein during multiple blood sampling of mice. Lab Anim. 2010 Jan;44(1):25-9. doi: 10.1258/la.2009.009017. Epub 2009 Jun 17. PMID: 19535392.
* Crisp RL, Solari L, Gammella D, Schvartzman GA, Rapetti MC, Donato H. Use of capillary blood to diagnose hereditary spherocytosis. Pediatr Blood Cancer. 2012 Dec 15;59(7):1299-301. doi: 10.1002/pbc.24157. Epub 2012 Apr 5. PMID: 22488885.
* Cornes M. Case report of unexplained hypocalcaemia in a slightly haemolysed sample. Biochem Med (Zagreb). 2017 Jun 15;27(2):426-429. doi: 10.11613/BM.2017.046. PMID: 28694734; PMCID: PMC5493164.
* Clarin M, Simrén J, Svanberg J, Fahlén H, Andreasson U, Zetterberg H. Influence of pneumatic tube system transport on cell count and spectrophotometry in cerebrospinal fluid. Scand J Clin Lab Invest. 2025;85(8):689-694. doi: 10.1080/00365513.2025.2605636. Epub 2025 Dec 17. PMID: 41406336.
* Dobrijević D, Pastor K. When Hemolysis Misleads: Implications for the Clinical Interpretation of Enzyme Activities in Pediatric Samples. Medicina (Kaunas). 2026 Sep 7;62(9). doi: 10.3390/medicina62091724. Epub 2026 Sep 7. PMID: 42796331; PMCID: PMC13609769.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.